[1]
N. Szerenos, “CARDIOVASCULAR BENEFITS OF GLP-1 RECEPTOR AGONISTS: EVIDENCE FROM CARDIOVASCULAR OUTCOMES TRIALS (CVOTs)”, IJITSS, vol. 1, no. 3(51), Jul. 2026, doi: 10.31435/ijitss.3(51).2026.6150.